2008
27 November 2008
Dr Bob Irving, CEO, Interstitial NanoSystems is a member of the Scientific Advisory Board for the upcoming commercial and applications based BIT Life Sciences 1st Annual International Congress of Antibody to be held in Beijing, May 22nd-24th 2009. Dr Irving will be presenting the molecular evolution and diagnostic activities entitled “The applications of antibodies to nanotechnology-based diagnostics, targeting and nanoarrays”. Further information can be found on the Congress website.
13 November 2008
An article around the Interstitial NS nVac technology has been published in the October on-line edition of the journal Vaccine. The research, led by Prof Colin Pouton and Dr Paul White from Monash Pharmacy and Pharmaceutical Sciences, entitled Generic construction of single component particles that elicit humoural and cellular immune responses without the need for adjuvants highlights the advantages of nanoformulated vaccines.
13 November 2008
Dr Bob Irving and Dr Michelle Critchley of Interstitial NanoSystems will be attending the Sir Mark Oliphant Inaugural Conference on Medical Bionics.
More…
13 November 2008
Leah Heiss will be holding a solo exhibition of her previous and current work with NanoVic and Interstitial NanoSystems at the RMIT Gallery, Melbourne, from November 6th - 27th.
More…
15 August 2008
Dr Bob Irving of Nanotechnology Victoria Ltd (NanoVic) and Interstitial NanoSystems and Dr Shin-Hwan Wang of DR. Chip Biotechnology Inc., Taiwan have signed an MOU in Hsinchu, Taiwan for potential future activities and cross-licensing opportunities in the fields of Nano Arrays and Diagnostic Biochips.
More…
11 July 2008
The Interstitial NS NanoMAP product has been highlighted in an Article in the journal Industrial Pharmacy. The article Nanotechnology Advances in Drug Delivery Methods: Transdermal Delivery with Micro-array Patches gives an overview of the technology for the non-invasive delivery of nanoparticulate drugs and vaccines.
2 July 2008
The Micro/Nano Physics Research Laboratory at Monash University was officially opened last night by Innovation Minister Hon Gavin Jennings. The MNRL is a state-of-the-art facility within the Monash University Biological Engineering Department. More…
19 May 2008
Interstitial NanoSystems has recently completed a Business Plan for the development of technology platforms around Bioengineering, Nano-formulation and Delivery. The Business Plan, prepared by Capstone Partners, is available on request. For further information, please email investment@interstitial.com.au
7 April 2008
Interstitial NS is working with Nanotechnology Victoria Artist in Residence, Leah Heiss, to develop jewellery and clothing that may have therapeutic applications. More…
17 March 2008
A recent publication around the Interstitial NS Pulmonary SAW technology has been published in the April edition of the journal Nanotechnology More…
« Previous Entries
|
